Cargando…

65 Clinical outcomes of chronic “Prairie Epidemic Strain” Pseudomonas aeruginosa infection in adults with cystic fibrosis

OBJECTIVES: Transmissible Pseudomonas aeruginosa (PA) strains have been described in CF and may be associated with a poorer prognosis. The “Prairie Epidemic Strain” (PES) has been recently identified in up to 30% of patients at prairie-based CF centres, however, its clinical impact remains to be det...

Descripción completa

Detalles Bibliográficos
Autores principales: Somayaji, R., Lam, J., Surette, M., Waddell, B., Purighalla, S., Sibley, C., Rabin, H.R., Parkins, M.D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Cystic Fibrosis Society. Published by Elsevier B.V. 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7129143/
http://dx.doi.org/10.1016/S1569-1993(15)30242-3
_version_ 1783516720466493440
author Somayaji, R.
Lam, J.
Surette, M.
Waddell, B.
Purighalla, S.
Sibley, C.
Rabin, H.R.
Parkins, M.D.
author_facet Somayaji, R.
Lam, J.
Surette, M.
Waddell, B.
Purighalla, S.
Sibley, C.
Rabin, H.R.
Parkins, M.D.
author_sort Somayaji, R.
collection PubMed
description OBJECTIVES: Transmissible Pseudomonas aeruginosa (PA) strains have been described in CF and may be associated with a poorer prognosis. The “Prairie Epidemic Strain” (PES) has been recently identified in up to 30% of patients at prairie-based CF centres, however, its clinical impact remains to be determined. METHODS: A cohort study of adults with cystic fibrosis from 1981–2014 was conducted and all PA isolates from clinical visits were prospectively collected. PA strain typing at clinic enrolment, and most recent was conducted by PFGE. Patients were divided into one of four cohorts: no PA, transient PA, unique chronic PA, and chronic PES. Random effects and proportional Cox hazard models were conducted for outcome of death, transplantation and FEV1% decline. RESULTS: 204 patients (54% male) with CF were analysed: 38 no PA, 20 transient PA, 103 unique PA, 43 PES. Baseline FEV1% was lowest in the chronic PES group (p = 0.002). Overall rate of FEV1% decline was –1.19%/year (95% CI: –1.41 to –0.97, p<0.001); the chronic PES group had the greatest rate of decline at –1.24%/year (p<0.001). There were a total of 42 deaths and 37 transplants through 1862 and 2050 follow-up years, respectively. The age-adjusted hazard ratio (HR) for death was not different for the PA groups compared to the no PA group. Relative to the no PA group, risk of transplant was increased in those with chronic PES (HR 9.13, CI 1.29–69, p = 0.032) compared to the no PA group. CONCLUSION: Chronic PES infection is significantly associated with a greater rate of FEV1% decline and risk of lung transplantation but not with increased risk of death compared to no PA infection.
format Online
Article
Text
id pubmed-7129143
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher European Cystic Fibrosis Society. Published by Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-71291432020-04-08 65 Clinical outcomes of chronic “Prairie Epidemic Strain” Pseudomonas aeruginosa infection in adults with cystic fibrosis Somayaji, R. Lam, J. Surette, M. Waddell, B. Purighalla, S. Sibley, C. Rabin, H.R. Parkins, M.D. J Cyst Fibros Article OBJECTIVES: Transmissible Pseudomonas aeruginosa (PA) strains have been described in CF and may be associated with a poorer prognosis. The “Prairie Epidemic Strain” (PES) has been recently identified in up to 30% of patients at prairie-based CF centres, however, its clinical impact remains to be determined. METHODS: A cohort study of adults with cystic fibrosis from 1981–2014 was conducted and all PA isolates from clinical visits were prospectively collected. PA strain typing at clinic enrolment, and most recent was conducted by PFGE. Patients were divided into one of four cohorts: no PA, transient PA, unique chronic PA, and chronic PES. Random effects and proportional Cox hazard models were conducted for outcome of death, transplantation and FEV1% decline. RESULTS: 204 patients (54% male) with CF were analysed: 38 no PA, 20 transient PA, 103 unique PA, 43 PES. Baseline FEV1% was lowest in the chronic PES group (p = 0.002). Overall rate of FEV1% decline was –1.19%/year (95% CI: –1.41 to –0.97, p<0.001); the chronic PES group had the greatest rate of decline at –1.24%/year (p<0.001). There were a total of 42 deaths and 37 transplants through 1862 and 2050 follow-up years, respectively. The age-adjusted hazard ratio (HR) for death was not different for the PA groups compared to the no PA group. Relative to the no PA group, risk of transplant was increased in those with chronic PES (HR 9.13, CI 1.29–69, p = 0.032) compared to the no PA group. CONCLUSION: Chronic PES infection is significantly associated with a greater rate of FEV1% decline and risk of lung transplantation but not with increased risk of death compared to no PA infection. European Cystic Fibrosis Society. Published by Elsevier B.V. 2015-06 2015-06-05 /pmc/articles/PMC7129143/ http://dx.doi.org/10.1016/S1569-1993(15)30242-3 Text en Copyright © 2015 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Somayaji, R.
Lam, J.
Surette, M.
Waddell, B.
Purighalla, S.
Sibley, C.
Rabin, H.R.
Parkins, M.D.
65 Clinical outcomes of chronic “Prairie Epidemic Strain” Pseudomonas aeruginosa infection in adults with cystic fibrosis
title 65 Clinical outcomes of chronic “Prairie Epidemic Strain” Pseudomonas aeruginosa infection in adults with cystic fibrosis
title_full 65 Clinical outcomes of chronic “Prairie Epidemic Strain” Pseudomonas aeruginosa infection in adults with cystic fibrosis
title_fullStr 65 Clinical outcomes of chronic “Prairie Epidemic Strain” Pseudomonas aeruginosa infection in adults with cystic fibrosis
title_full_unstemmed 65 Clinical outcomes of chronic “Prairie Epidemic Strain” Pseudomonas aeruginosa infection in adults with cystic fibrosis
title_short 65 Clinical outcomes of chronic “Prairie Epidemic Strain” Pseudomonas aeruginosa infection in adults with cystic fibrosis
title_sort 65 clinical outcomes of chronic “prairie epidemic strain” pseudomonas aeruginosa infection in adults with cystic fibrosis
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7129143/
http://dx.doi.org/10.1016/S1569-1993(15)30242-3
work_keys_str_mv AT somayajir 65clinicaloutcomesofchronicprairieepidemicstrainpseudomonasaeruginosainfectioninadultswithcysticfibrosis
AT lamj 65clinicaloutcomesofchronicprairieepidemicstrainpseudomonasaeruginosainfectioninadultswithcysticfibrosis
AT surettem 65clinicaloutcomesofchronicprairieepidemicstrainpseudomonasaeruginosainfectioninadultswithcysticfibrosis
AT waddellb 65clinicaloutcomesofchronicprairieepidemicstrainpseudomonasaeruginosainfectioninadultswithcysticfibrosis
AT purighallas 65clinicaloutcomesofchronicprairieepidemicstrainpseudomonasaeruginosainfectioninadultswithcysticfibrosis
AT sibleyc 65clinicaloutcomesofchronicprairieepidemicstrainpseudomonasaeruginosainfectioninadultswithcysticfibrosis
AT rabinhr 65clinicaloutcomesofchronicprairieepidemicstrainpseudomonasaeruginosainfectioninadultswithcysticfibrosis
AT parkinsmd 65clinicaloutcomesofchronicprairieepidemicstrainpseudomonasaeruginosainfectioninadultswithcysticfibrosis